DIA Biosimilars USA 2022

INICIO/Congresos | Posted 18/03/2022 post-comment0 Post your comment

Collaborate for Progress at DIA’s Biosimilars Conference in Arlington, VA – 20–21 September 2022

DIA’s Biosimilars Conference USA 2022
20–21 September 2022 | Arlington, Virginia, USA

Innovations in biosimilars development spur industry-wide foundational improvements to healthcare processes. The DIA Biosimilars Conference invites transparent discussion and collaborative problem-solving between individuals impacted by biosimilars development and approval. Industry-wide manufacturers, regulators, prescribers, patients, and many more will gather to share global perspectives and relevant learnings to confront current industry challenges. Addressing these concerns in a transparent setting serves worldwide efforts and stakeholder goals to create and expedite more efficient, effective biological therapies to patients.

 For more information, please visit www.diaglobal.org/Bios2022

comment icon Comments (0)
Post your comment
Most viewed articles
Sobre GaBI
INICIO/Sobre GaBI Posted 05/08/2009
EU guidelines for biosimilars
EMA logo 1 V13C15
INICIO/Directrices Posted 08/10/2010